| Nader Tehrani, MD | |
|
880 W Central Rd Ste 7100, Arlington Heights, IL 60005-2379 | |
| (847) 618-3800 | |
| (847) 618-3809 |
| Full Name | Nader Tehrani |
|---|---|
| Gender | Male |
| Speciality | Vascular Surgery |
| Experience | 10 Years |
| Location | 880 W Central Rd Ste 7100, Arlington Heights, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013322973 | NPI | - | NPPES |
| 036110448 | Other | IL | STATE LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2086S0129X | Surgery - Vascular Surgery | 036.149554 (Illinois) | Primary |
| 208600000X | Surgery | 125.064955 (Illinois) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northwest Community Hospital 1 | Arlington heights, IL | Hospital |
| Advocate Christ Hospital & Medical Center | Oak lawn, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Northwest Community Health Services Inc | 3375737331 | 275 |
News Archive
Amorfix Life Sciences, a product development company focused on the development of diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three and six months ended September 30, 2010.
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity. A team of researchers from the University of California, Santa Barbara (UCSB) in Santa Barbara, CA has demonstrated a novel formulation of propranolol as a liquid salt which enables delivery through skin with reduced toxicity.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate of physician and patient satisfaction and persistent improvements in overall outcomes of the procedure at six and 12 months.
House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.
› Verified 9 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
Amorfix Life Sciences, a product development company focused on the development of diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three and six months ended September 30, 2010.
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity. A team of researchers from the University of California, Santa Barbara (UCSB) in Santa Barbara, CA has demonstrated a novel formulation of propranolol as a liquid salt which enables delivery through skin with reduced toxicity.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate of physician and patient satisfaction and persistent improvements in overall outcomes of the procedure at six and 12 months.
House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.
› Verified 9 days ago
| Entity Name | Northwest Community Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134433154 PECOS PAC ID: 3375737331 Enrollment ID: O20101103000837 |
News Archive
Amorfix Life Sciences, a product development company focused on the development of diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three and six months ended September 30, 2010.
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity. A team of researchers from the University of California, Santa Barbara (UCSB) in Santa Barbara, CA has demonstrated a novel formulation of propranolol as a liquid salt which enables delivery through skin with reduced toxicity.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate of physician and patient satisfaction and persistent improvements in overall outcomes of the procedure at six and 12 months.
House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.
› Verified 9 days ago
| Entity Name | Vascular Surgery Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538791793 PECOS PAC ID: 0345678132 Enrollment ID: O20200309002184 |
News Archive
Amorfix Life Sciences, a product development company focused on the development of diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three and six months ended September 30, 2010.
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity. A team of researchers from the University of California, Santa Barbara (UCSB) in Santa Barbara, CA has demonstrated a novel formulation of propranolol as a liquid salt which enables delivery through skin with reduced toxicity.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate of physician and patient satisfaction and persistent improvements in overall outcomes of the procedure at six and 12 months.
House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nader Tehrani, MD 880 W Central Rd Ste 7100, Arlington Heights, IL 60005-2379 Ph: (847) 618-3800 | Nader Tehrani, MD 880 W Central Rd Ste 7100, Arlington Heights, IL 60005-2379 Ph: (847) 618-3800 |
News Archive
Amorfix Life Sciences, a product development company focused on the development of diagnostics and therapeutics for misfolded protein diseases, today announced its operational and financial results for the three and six months ended September 30, 2010.
Formulating drugs as liquid salts may provide a safe and efficient strategy for topical delivery of drugs that cause skin toxicity. A team of researchers from the University of California, Santa Barbara (UCSB) in Santa Barbara, CA has demonstrated a novel formulation of propranolol as a liquid salt which enables delivery through skin with reduced toxicity.
A pair of targeted therapies shrank tumors in some patients with treatment-resistant Ewing's sarcoma or desmoplastic small-round-cell tumors, according to research led by investigators from The University of Texas MD Anderson Cancer Center reported at the AACR Annual Meeting 2012.
Interim results from a breast reconstruction trial show stem and regenerative cell-enriched fat grafting resulted in a high sustained rate of physician and patient satisfaction and persistent improvements in overall outcomes of the procedure at six and 12 months.
House Appropriations Committee Chairman David Obey, D-Wis., said Wednesday that groups pressing for $14 billion more in funding for education, health and labor programs will likely be disappointed because the budget proposed by President Barack Obama already faces cuts of about $3.5 billion in those areas.
› Verified 9 days ago
Dr. Michaela Simcha Klein, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1640 N Arlington Heights Rd Ste 201, Arlington Heights, IL 60004 Phone: 800-991-6117 Fax: 888-812-8191 | |
William D Soper, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Dr. Roman Victor Voytsekhovskiy, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1700 W Central Rd, Arlington Heights, IL 60005 Phone: 847-259-1000 | |
Dr. John D Edwards, MD Surgery Medicare: Medicare Enrolled Practice Location: 880 W Central Rd, Suite 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 | |
Mrs. Yelena Levitin, M.D Surgery Medicare: Accepting Medicare Assignments Practice Location: 129 W Rand Rd, Suite 1, Arlington Heights, IL 60004 Phone: 847-215-0530 Fax: 847-215-0951 | |
Sean Patrick Barnett, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 880 W Central Rd Ste 5000, Arlington Heights, IL 60005 Phone: 847-618-3800 Fax: 847-618-3809 |